Company · founded 2009

Nubad (United States)

Greenville, United States · nubadllc.com

Manage this page

Citations, last 5 years: 180
Works, last 5 years: 13
h-index: 22
Scientists listed: 5
Grants since 2016: 33

Grants received

2022–2025 · research · R44

Ototoxicity of modified aminoglycosides

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$1,000kHearing, Cochlea, Tinnitus, Genetics

2022–2024 · research · R43

A biophysical assay targeting Gyrase RNA

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$294.5k

2022–2026 · research · R43

A biophysical assay targeting Gyrase RNA

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$226.5k

2022–2024 · research · R43

A biophysical assay targeting SARS CoV-2 RNA

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$299.9k

2022–2025 · research · R44

Ototoxicity of modified aminoglycosides

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$989.2kHearing, Cochlea, Tinnitus, Genetics

2022–2026 · research · R43

A biophysical assay targeting SARS CoV-2 RNA

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$298.7k

2022–2026 · research · R44

Ototoxicity of modified aminoglycosides

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$1,000kHearing, Cochlea, Tinnitus, Genetics

2021–2025 · research · R42

Development of peptide nucleic acid antibiotics

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$1,000k

2021–2026 · research · R42

Development of peptide nucleic acid antibiotics

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$998.6k

2021–2025 · research · R42

Development of peptide nucleic acid antibiotics

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$999.6k

2021–2025 · research · R42

Development of peptide nucleic acid antibiotics

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$33.3k

2021–2023 · research · R43

A biophysical assay targeting an essential bacterial gene

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$294.5k

2021–2024 · research · R43

A biophysical assay targeting an essential bacterial gene

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$194k

2021–2026 · research · R42

Development of peptide nucleic acid antibiotics-supplement 1

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$133.1kAntimicrobial Peptides and Activities

2020–2022 · research · R41

Delivery of chemically modified PNA oligomers

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$300kRNA Interference and Gene Delivery

2020–2022 · research · R41

Supplement Request LIDIA.AZANKIA

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$13.5k

2020–2025 · research · R42

Aminoglycosides with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$1,000kHearing, Cochlea, Tinnitus, Genetics

2020–2021 · research · R43

A biophysical assay for RNA based resistance

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$288.9k

2020–2025 · research · R42

Aminoglycosides with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$999.7kHearing, Cochlea, Tinnitus, Genetics

2020–2023 · research · R41

Delivery of chemically modified PNA oligomers

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$473.5kRNA Interference and Gene Delivery

2020–2022 · research · R43

A biophysical assay for RNA based resistance

Sandra Paige Story · Nubad (United States) · funded by National Institutes of Health

$139.8k

2020–2026 · research · R42

Aminoglycosides with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$999.7kHearing, Cochlea, Tinnitus, Genetics

2020–2022 · research · R41

Supplement Request Alain Letou

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$16.8k

2019–2021 · research · R41

Aminoglycosides with reduced ototoxicity via miRNA targeting

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$12.3kHearing, Cochlea, Tinnitus, Genetics

2019–2021 · research · R41

Aminoglycosides with reduced ototoxicity via miRNA targeting

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$44.9kHearing, Cochlea, Tinnitus, Genetics

2019–2023 · research · R41

Aminoglycosides with reduced ototoxicity via miRNA targeting

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$397.7kHearing, Cochlea, Tinnitus, Genetics

2019–2021 · research · R41

Aminoglycosides with reduced ototoxicity via miRNA targeting

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$300kHearing, Cochlea, Tinnitus, Genetics

2017–2021 · research · R41

Nucleobase aminosugars with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$364.4kHearing, Cochlea, Tinnitus, Genetics

2017–2019 · research · R41

Nucleobase aminosugars with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$305.9kHearing, Cochlea, Tinnitus, Genetics

2016–2020 · research · R41

Screening the Ribosome for New Target Sites

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$325kRNA and protein synthesis mechanisms

2016–2018 · research · R41

Aminoglycosides with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$300kHearing, Cochlea, Tinnitus, Genetics

2016–2018 · research · R41

Screening the Ribosome for New Target Sites

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$325kRNA and protein synthesis mechanisms

2016–2020 · research · R41

Aminoglycosides with reduced ototoxicity

Dev Priya Arya · Nubad (United States) · funded by National Institutes of Health

$300kHearing, Cochlea, Tinnitus, Genetics